These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1088 related articles for article (PubMed ID: 7656781)
1. [The antitumor activities of gnidimacrin isolated from Stellera chamaejasme L]. Feng W; Tetsuro I; Mitsuzi Y Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):24-6. PubMed ID: 7656781 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of daphnane-type diterpene gnidimacrin isolated from Stellera chamaejasme L. Yoshida M; Feng W; Saijo N; Ikekawa T Int J Cancer; 1996 Apr; 66(2):268-73. PubMed ID: 8603823 [TBL] [Abstract][Full Text] [Related]
3. [The antitumor effects of total-flavonoid from Stellera chamaejasmel]. Wang M; Jia ZP; Ma J; Wang B Zhongguo Zhong Yao Za Zhi; 2005 Apr; 30(8):603-6. PubMed ID: 16011286 [TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518 [TBL] [Abstract][Full Text] [Related]
5. [The antitumor activities of the extracts from Stellera chamaejasmel L. in vitro by means of systematic solvent extraction]. Wang B; Wang R; Jia Z; Fan J; Ma J; Zhang R Zhong Yao Cai; 2004 May; 27(5):355-7. PubMed ID: 15376391 [TBL] [Abstract][Full Text] [Related]
6. Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action. Ojo-Amaize EA; Nchekwube EJ; Cottam HB; Bai R; Verdier-Pinard P; Kakkanaiah VN; Varner JA; Leoni L; Okogun JI; Adesomoju AA; Oyemade OA; Hamel E Cancer Res; 2002 Jul; 62(14):4007-14. PubMed ID: 12124334 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of antitumor action of PKC activator, gnidimacrin. Yoshida M; Yokokura H; Hidaka H; Ikekawa T; Saijo N Int J Cancer; 1998 Jul; 77(2):243-50. PubMed ID: 9650560 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of trewiasine in 4 human cancer cell lines and 5 murine tumors. Yue XF; Han JX; Shen ZM; Yang WY; Lu LJ; Li BJ; Wang C; Xu XK Zhongguo Yao Li Xue Bao; 1992 May; 13(3):252-5. PubMed ID: 1442109 [TBL] [Abstract][Full Text] [Related]
9. Involvement of PKC betaII in anti-proliferating action of a new antitumor compound gnidimacrin. Yoshida M; Heike Y; Ohno S; Ikekawa T; Wakasugi H Int J Cancer; 2003 Jul; 105(5):601-6. PubMed ID: 12740906 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of novel ailanthone derivatives in vitro and in vivo. Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149 [TBL] [Abstract][Full Text] [Related]
11. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin. Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts. Petrangolini G; Pratesi G; De Cesare M; Supino R; Pisano C; Marcellini M; Giordano V; Laccabue D; Lanzi C; Zunino F Mol Cancer Res; 2003 Oct; 1(12):863-70. PubMed ID: 14573787 [TBL] [Abstract][Full Text] [Related]
14. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors. Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug. Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae). Da Silva SL; Chaar Jda S; Yano T Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998 [TBL] [Abstract][Full Text] [Related]
17. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots. Kimura Y; Taniguchi M; Baba K Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497 [TBL] [Abstract][Full Text] [Related]
18. Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts. Fodstad O; Breistøl K; Pettit GR; Shoemaker RH; Boyd MR J Exp Ther Oncol; 1996 Mar; 1(2):119-25. PubMed ID: 9414395 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo. Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044 [TBL] [Abstract][Full Text] [Related]
20. [Studies on the anticancer effect of howiinol A, a new compound isolated from Goniothalamus howii]. He J; Ye Y; Xu C Yao Xue Xue Bao; 1998 Jul; 33(7):493-7. PubMed ID: 12016881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]